Title The medical uses and side effects of etanercept with a focus on cutaneous disease.
Author(s) Scheinfeld N
Institution Department of Dermatology, St Luke's-Roosevelt Hospital Center, New York, NY 10025, USA. Scheinfeld@earthlink.net
Source J Drugs Dermatol 2004 Nov-Dec; 3(6) :653-9.
MeSH Anti-Inflammatory Agents, Non-Steroidal
Humans
Immunoglobulin G
Psoriasis
Receptors, Tumor Necrosis Factor
Recombinant Fusion Proteins
Abstract Etanercept is a dimeric fusion protein that has been approved for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, active ankylosing spondylitis and moderate to severe plaque psoriasis. It has been reported to be useful in other variants of psoriasis, Still's disease, recurrent aphthous ulcers, and a variety of rare cutaneous conditions. Its cutaneous side effects are rare and include injection site reactions, cutaneous lupus, and cutaneous vasculitis. Its systemic side effects are also rare and include induction or worsening of infections, lupus, multiple sclerosis, and congestive heart failure. Linkage to an increased risk of lymphoma is unclear. In short, etanercept is a promising medication with substantial benefits and use will probably increase in the future. This review surveys off-label uses and side effects of etanercept.
Language eng
Pub Type(s) Journal Article
Review
PubMed ID 15624748
Comments